Improved Treatment for Primary HIV Infection by Interferon-Alfa Therapy? Does HCV Treatment in HIV/HCV Coinfected Patients Help Us to Test This Hypothesis?

被引：0
|
作者：
zur Wiesch, Julian Schulze [1 ,2 ]
van Lunzen, Jan [1 ,2 ]
机构：
[1] Univ Med Ctr Hamburg Eppendorf, Infect Dis Unit, Dept Internal Med, D-20251 Hamburg, Germany
[2] Leibniz Inst Expt Virol, Heinrich Pette Inst, D-20251 Hamburg, Germany
来源：
JOURNAL OF INFECTIOUS DISEASES | 2013年 / 208卷 / 02期
关键词：
CHRONIC HEPATITIS-C; ANTIRETROVIRAL THERAPY; PLUS RIBAVIRIN; VIRUS; REPLICATION; DNA;
D O I：
10.1093/infdis/jit159
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：362 / 362
页数：1
相关论文
共 50 条
  • [31] Higher frequency of occult HCV infection in HIV/HCV coinfected patients with advanced liver disease: Post DAAs treatment observation
    Bagaglio, Sabrina
    Messina, Emanuela
    Vercesi, Riccardo
    Morsica, Giulia
    Salpietro, Stefania
    Bigoloni, Alba
    Della Torre, Liviana
    Concetta, Vinci
    Lazzarin, Adriano
    Uberti-Foppa, Caterina
    Hasson, Hamid
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E726 - E727
  • [32] Baseline factors associated with haematological toxicity of pegylated interferon α-2a and ribavirin for the treatment of HCV infection in HIV coinfected patients
    Fuster, D
    Galeras, JA
    Gómez, G
    Huertas, JA
    González, J
    Vilaró, J
    Force, L
    García, I
    Roget, M
    Cervantes, M
    Pedrol, E
    Tor, J
    Ballesteros, AL
    Planas, R
    Videla, S
    Sirera, G
    Clotet, B
    Tural, C
    JOURNAL OF HEPATOLOGY, 2005, 42 : 230 - 231
  • [33] Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patients
    Rice, Donald P.
    Ordoveza, Michelle A.
    Palmer, Ann M.
    Wu, George Y.
    Chirch, Lisa M.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (12): : 1507 - 1511
  • [34] Extending treatment for HCV infection to HIV-HCV coinfected individuals with psychiatric illness and drug dependence - Reply
    Fleming, CA
    Craven, DE
    Thornton, D
    Tumilty, S
    Nunes, D
    CLINICAL INFECTIOUS DISEASES, 2003, 36 (11) : 1502 - 1503
  • [35] HCV E2 genomic variability in HCV-HIV-coinfected patients under interferon therapy.
    Neau, D
    Jouvencel, AC
    Trimoulet, P
    Legrand, E
    Dupon, M
    Ragnaud, JM
    Fleury, H
    Lafon, ME
    HEPATOLOGY, 2001, 34 (04) : 413A - 413A
  • [36] Optimizing hepatitis C therapy in HIV/hepatitis C virus (HCV) coinfected patients: Analysis of HCV viral kinetics on treatment
    James, Paul Damien
    Wong, David K. H.
    CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2012, 23 (01): : 31 - 35
  • [37] Peritransplant treatment with Direct Acting Antivirals of HIV-HCV coinfected patients
    Vinaixa, Carmen
    Aguilera, Victoria
    Rubin, Angel
    Garcia, Maria
    Blanes, Marino
    Benlloch, Salvador
    Prieto, Martin
    Berenguer, Marina
    Juan, Fernando San
    HEPATOLOGY, 2016, 64 : 807A - 808A
  • [38] HIV and HCV coinfected haemophilia patients: what are the best options of orthopaedic treatment?
    Rodriguez-Merchan, EC
    HAEMOPHILIA, 2006, 12 : 90 - 101
  • [39] Treatment of HCV/HIV coinfection with leukocyte derived interferon alfa-n3.
    Sherman, KE
    Lalezari, J
    Brand, JD
    Yoffe, B
    Yangco, B
    Fedorczyk, D
    GASTROENTEROLOGY, 2000, 118 (04) : A1487 - A1487
  • [40] Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients:: The impact on the different dimensions of fatigue and self-reported side effects
    Marcellin, Fabienne
    Preau, Marie
    Dellamonica, Pierre
    Ravaux, Isabelle
    Kurkdji, Patrick
    Protopopescu, Camelia
    Carrieri, Maria Patrizia
    Spire, Bruno
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2007, 34 (04) : 413 - 421
12345